Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Incyte identifies human monocyte chemotactic proprotein

March 27, 1998

Nonpeptide substance P antagonists reported by Merck & Co.

March 27, 1998

New drug therapy option for colonic polyps described

March 27, 1998

AHP discovers centrally active muscarinic agents

March 27, 1998

Byk Gulden claims PDE IV inhibitors for respiratory disorders, dermatoses

March 27, 1998

Oxazolidinone antibacterial agents in development at Zeneca

March 27, 1998

Novel compounds for allergic/inflammatory disorders discovered at Astra

March 27, 1998

New treatments for preterm labor from Merck

March 26, 1998

First report of nonpeptide compounds as MHC class II inhibitors

March 26, 1998

Vacuolar ATPase inhibitors claimed by SmithKline Beecham for osteoporosis

March 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...